The Biostar Stem Cell Research Institute wishes to brief you on the progress of the VascoStem and JointStem R&D project at the General Meeting of Shareholders of Nature Cell on September 11, 2015.
Read more
The results of a study confirming the possibility of extending the health and life spans through intravenous injections of adult stem cells were announced by a domestic research team.
Read more
The Biostar Stem Cell Research Institute, jointly operated by Nature Cell and R Bio, announced on August 21 that it has been notified by the Ministry of Food and Drug Safety (MFDS) that the date of decision-making regarding the orphan drug designation of VascoStem, a stem cell treatment agent for Buerger’s disease, has been postponed to September 14.
Read more
The Biostar Stem Cell Research Institute, jointly run by Nature Cell and R Bio, made an announcement on August 13 that it has submitted an application to the Ministry of Health, Labour and Welfare (MHLW) of Japan for an approval of manufacturing processed cellular products at a cell processing center in Korea.
Read more
Joint research led by Suh Yoo-hun, the President of the Korea Brain Research Institute, Dr. Jang Geun-ah, a Professor at the Gachon University School of Medicine, and Ra Jeong-chan, the President of the Biostar Stem Cell Research Institute
Read more
Our organization was born again as R Bio, based on the resolution reached at the General Meeting of Shareholders held on June 29, 2015, and for this, we would like to extend our gratitude to all the stakeholders.
Read more
Biostar Stem Cell Research Institute
08506
305, Lotte IT Castle Building #2, 550-1, Gasan-dong, Geumcheon-gu, Seoul
R Bio Co.,Ltd.
+82 -2-858-8021~5
Most Commented